ATECMEDIUM SIGNALFINANCIAL10-K

ATEC shows improving operational performance with reduced losses and strong revenue growth, though interest expense has increased substantially.

The company's operating loss narrowed meaningfully while gross profit expanded robustly alongside revenue growth, indicating improving operational efficiency and market traction. However, the substantial increase in interest expense suggests higher debt servicing costs that investors should monitor, particularly given the company's current loss position.

Comparing 2026-02-24 vs 2025-02-26View on EDGAR →
FINANCIAL ANALYSIS

ATEC demonstrated strong top-line momentum with gross profit expanding notably and operating losses narrowing significantly year-over-year. Interest expense increased substantially, likely reflecting higher debt levels or borrowing costs, while current liabilities grew meaningfully. The company maintained a solid cash position with modest growth, and meaningfully reduced capital expenditures, suggesting more disciplined spending while still investing in growth.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+84.6%
$24.9M$45.9M

Interest expense surged 84.6% — significant debt increase or rising rates materially impacting earnings.

Capital Expenditure
Cash Flow
-49%
$83.2M$42.5M

Capex reduced 49% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Current Liabilities
Balance Sheet
+43.2%
$153.0M$219.2M

Current liabilities surged 43.2% — significant near-term obligations; verify ability to meet short-term debt.

Operating Income
P&L
+39.7%
-$136.2M-$82.1M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Gross Profit
P&L
+25.4%
$424.3M$531.9M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Accounts Receivable
Balance Sheet
+17.3%
$83.0M$97.3M

Receivables grew 17.3% — monitor days sales outstanding for collection efficiency.

Cash & Equivalents
Balance Sheet
+15.8%
$138.8M$160.8M

Cash grew 15.8% — improving liquidity position supports investment and shareholder returns.

Revenue
P&L
-15.4%
$120.2M$101.7M

Revenue softened 15.4% — monitor whether this is cyclical or structural.

Net Income
P&L
+11.6%
-$162.1M-$143.4M

Net income grew 11.6% — bottom-line growth signals improving overall business health.

SG&A Expense
P&L
+10.7%
$450.2M$498.5M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

LANGUAGE CHANGES
NEW — 2026-02-24
PRIOR — 2025-02-26
ADDED
The number of outstanding shares of the registrant s common stock, par value $0.0001 per share, as of February 17, 2026 was 151,356,620 .
Total revenue was $764.2 million for the year ended December 31, 2025, representing an increase of $152.6 million, or 25% compared to $611.6 million for the year ended December 31, 2024.
SafeOp became the informational foundation of the Prone TransPsoas ( PTP ) approach, which we developed and launched in 2020 as an advancement designed to address the limitations of first-generation lateral spine surgery.
We also acquired EOS Imaging, a technology platform that enables full-body, calibrated 3D imaging and integrates across the continuum of spine patient care to enhance procedure planning and improve and quantify the assessment of global alignment.
We applied learnings from PTP to develop and introduce the Lateral TransPsoas ( LTP ) and Midline ALIF approaches.
+7 more — sign up free →
REMOVED
The number of outstanding shares of the registrant s common stock, par value $0.0001 per share, as of February 19, 2025 was 144,149,232 .
Total revenue was $611.6 million for the year ended December 31, 2024, representing an increase of $129.3 million, or 27% compared to $482.3 million for the year ended December 31, 2023.
SafeOp became the informational foundation of the Prone TransPsoas ( PTP ) approach, which we developed and launched in 2020 to advance first-generation lateral spine surgery.
We also acquired EOS imaging, technology that enables full-body, calibrated, 3D-images that integrate throughout the span of spine patient care to influence procedure planning and improve and quantify the understanding of global alignment.
We applied learnings from PTP to develop and introduce the Lateral TransPsoas ("LTP") and Midline ALIF approaches.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →